Background: Plasmodium falciparum causes placental malaria, which results in adverse
outcomes for mother and child. P. falciparum-infected erythrocytes that express the parasite …

Background Recent reports suggest that pregnant women living in holoendemic regions of
sub-Sahara Africa die in great numbers annually due to malaria disease resulting from their …

Malaria is an infectious disease which disproportionately effects children and pregnant
women. These vulnerable populations are often excluded from clinical trials resulting in one …

Background Malaria remains a major public health threat and tools sensitive to detect
infections in low malaria transmission areas are needed to progress elimination efforts …

Objective The current study aimed to estimate prevalence of malaria infection, especially
sub-patent infection, in pregnant women residing in high malaria-endemic, hard-to-reach …

Background In Kenya, health service delivery and access to health care remains a
challenge for vulnerable populations, particularly pregnant women and children below five …

Background Plasmodium falciparum malaria is a public health issue mostly seen in tropical
countries. Until now, there is no effective malaria vaccine against antigens specific to the …

Sequestration of Plasmodium falciparum-infected erythrocytes expressing the VAR2CSA
antigen in the placenta results in poor pregnancy outcomes, including low birth weight and …

Background Despite efforts to avert the negative effects of malaria, there remain barriers to
the uptake of prevention measures, and these have hindered its eradication. This study …

While two Plasmodium falciparum circumsporozoite protein-based pre-erythrocytic vaccines
(PEV), RTS, S and R21, have been approved by the WHO, no blood-stage vaccine (BSV) or …